Comparing end-of-life care of hematologic malignancy versus solid tumor patients in a tertiary care center.

Rachel Burstein,Ariel Aviv,Noa Gross Even-Zohar,Boaz Nachmias,Arnon Haran,Michal Braun,Yakir Rottenberg,Adir Shaulov

European journal of haematology（2023）

引用 0|浏览12

暂无评分

摘要

HM patients were more likely than solid tumor patients to undergo aggressive measures at EOL. Rarity of HM deaths, frequently caused by complications of treatment and unrelated causes, may affect treatment choices at EOL.

查看译文

关键词

cancer, EOL, hematology, palliative care

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要